Menu Search
Equities

Aptargroup Inc

AGT:BRN

Aptargroup Inc

Actions
  • Price (CHF)132.59
  • Today's Change0.00 / 0.00%
  • Shares traded114.00
  • 1 Year change--
  • Beta--
Data delayed at least 15 minutes, as of Sep 19 2024.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

AptarGroup, Inc. is engaged in designing and manufacturing of drug and consumer product dosing, dispensing and protection technologies. The Company serves various end markets, including pharmaceutical, beauty, food, beverage, personal care and home care. It operates in three segments. The Aptar Pharma segment sells proprietary dispensing systems, drug delivery systems, sealing solutions and services for the prescription drug, consumer health care, injectables, active material science solutions and digital health market. It also specializes in nasal drug delivery for delivering drugs. The Aptar Beauty segment sells dispensing systems and sealing solutions for the beauty, personal care and home care markets. The Aptar Closures segment sells dispensing systems, sealing solutions and food service trays to the food, beverage, personal care, home care, beauty and healthcare markets. This segment also includes the food protection business and the elastomeric flow-control technology business.

  • Revenue in USD (TTM)3.57bn
  • Net income in USD335.95m
  • Incorporated1992
  • Employees13.80k
  • Location
    Aptargroup Inc265 EXCHANGE DRIVE, SUITE 301CRYSTAL LAKE 60014United StatesUSA
  • Phone+1 (815) 477-0424
  • Fax+1 (815) 477-0481
  • Websitehttps://www.aptar.com/
More ▼

Mergers & acquisitions

Acquired companyDeal statusDateDate /
Deal status		ATR:NYQ since
announced		Transaction
value
SipNose Nasal Delivery Systems-Proprietary Portfolio AssetsDeal completed09 Oct 202409 Oct 2024Deal completed10.77%--
Data delayed at least 15 minutes, as of Nov 09 2024.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.